Generics - Asia-Pacific, Anti-virals

Filter

Current filters:

Asia-PacificAnti-virals

Popular Filters

Indian drugmakers show interest in investing in Zimbabwe

13-09-2012

Owen Mugurungi, director of the Aids and TB Unit in Zimbabwe's Ministry of Health Child and Welfare,…

Anti-viralsAsia-PacificGenericsProductionRest of the World

Mylan chosen to supply ARVs to India's national AIDS control body

04-09-2012

Leading USA-based generic drugmaker Mylan (Nasdaq: MYL) says that its India-based subsidiary Mylan Laboratories…

Anti-viralsAsia-PacificGenericsMarkets & MarketingMylan Laboratories

Mylan starts operating in India, with portfolio of ARVs

07-08-2012

US generics and specialty drugmaker Mylan (Nasdaq: MYL) says that its India based subsidiary, Mylan Pharmaceuticals…

Anti-viralsAsia-PacificGenericsMarkets & MarketingMylan Laboratories

Breckenridge in generic Viramune deal with Zhejiang Huahai Pharma

07-05-2012

Privately-held US generic drugmaker Breckenridge Pharmaceutical that it has finalized its agreement with…

Anti-viralsAsia-PacificBoehringer IngelheimBreckenridge PharmaceuticalsGenericsMarkets & MarketingNevirapineNorth AmericaPatentsViramuneZhejiang Huahai Pharma

Indian HIV drugs market forecast to reach $54 million by 2014

23-11-2011

The market for HIV drugs in India is expected to reach 454 million by 2014, according to a new report…

Anti-viralsAsia-PacificGenericsMarkets & MarketingPharmaceutical

Back to top